Skip to content

Effect of dexmedetomidine combined with flurbiprofenate on pulmonary oxygenation function and respiratory mechanics during one-lung ventilation with a blocker in obese patients undergoing thoracoscopic right lung cancer resection

Effect of dexmedetomidine combined with flurbiprofenate on pulmonary oxygenation function and respiratory mechanics during one-lung ventilation with a blocker in obese patients undergoing thoracoscopic right lung cancer resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077820
Enrollment
Unknown
Registered
2023-11-21
Start date
2023-11-10
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Dexmedetomidine group:Dexmedetomidine group pumped dexmedetomidine 0.5ug/kg LBW 30 min before anesthesia (administered over 10 min) and injected an equal dose of saline 15 min before anesthesia.
Flurbiprofenate group: Flurbiprofenac group (group F) pumped an equal dose of saline 30 min before anesthesia and injected a slow intravenous drip of flurbiprofenac 1.0 mg/kg LBW 15 min before anesthe
Dexmedetomidine combined with flurbiprofenate group:dexmedetomidine combined with flurbiprofenate group (group D+F) pumped Dexmedetomidine 0.5ug/kg LBW 30 min before anesthesia (administered over 10 m
Control group:The control group pumped an equal dose of saline and a slow intravenous drip of flurbiprofenate 30 min before anesthesia. saline and an equal dose of saline was injected 15 min before an

Sponsors

the Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 64 Years

Inclusion criteria

Inclusion criteria: Obese patients with elective thoracoscopic right pneumonectomy for lung cancer using one-lung ventilation with a blocker were selected, regardless of gender, aged 35-64 years, with a BMI of 28.0-34.9 kg/m2, and ASA class I-II.

Exclusion criteria

Exclusion criteria: Preoperative history of severe cardiovascular or respiratory disease, history of narcotic analgesic drug abuse, history of psychiatric and neurological disorders, patients with peptic ulcers, patients with severe hepatic, renal, and hematologic dysfunction, patients with severe heart failure, hypertension, patients with a history of allergy to dexmedetomidine, flurbiprofen ester, patients with aspirin asthma or a previous history of aspirin asthma, patients who are on ilofloxacin, lomefloxacin , norfloxacin, patients applying non-steroidal anti-inflammatory drugs within 24h before surgery, contraindication to flurbiprofenate use, lactation. Contraindication to right lung sequestration.

Design outcomes

Primary

MeasureTime frame
Oxygen saturation;PaCO2;PaO2;OI;

Secondary

MeasureTime frame
The blood pressure;heart rate;Ppeak;Pmean;Cdyn;The ratio of ineffective lumen to tidal volume;

Countries

China

Contacts

Public ContactHuanshuang Pei

the Fourth Hospital of Hebei Medical University

wxhmz99999@163.com+86 139 3012 5450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026